Clotet B - Search Results

1

Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages.

Ruiz A, Pauls E, Badia R, Torres-Torronteras J, Riveira-Muñoz E, Clotet B, Martí R, Ballana E, Esté JA. Ruiz A, et al. Among authors: clotet b. Cell Cycle. 2015;14(11):1657-65. doi: 10.1080/15384101.2015.1030558. Cell Cycle. 2015. PMID: 25927932 Free PMC article.

2

Anti-HIV activity of a novel aminoglycoside-arginine conjugate.

Cabrera C, Gutiérrez A, Barretina J, Blanco J, Litovchick A, Lapidot A, Clotet B, Esté JA. Cabrera C, et al. Among authors: clotet b. Antiviral Res. 2002 Jan;53(1):1-8. doi: 10.1016/s0166-3542(01)00188-7. Antiviral Res. 2002. PMID: 11684311

3

Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.

Blanco J, Barretina J, Gutiérrez A, Armand-Ugón M, Cabrera C, Clotet B, Esté JA. Blanco J, et al. Among authors: clotet b. AIDS Res Hum Retroviruses. 2002 Jan 1;18(1):27-38. doi: 10.1089/088922202753394691. AIDS Res Hum Retroviruses. 2002. PMID: 11804554

4

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.

Martínez MA, Gutiérrez A, Armand-Ugón M, Blanco J, Parera M, Gómez J, Clotet B, Esté JA. Martínez MA, et al. Among authors: clotet b. AIDS. 2002 Dec 6;16(18):2385-90. doi: 10.1097/00002030-200212060-00002. AIDS. 2002. PMID: 12461411

5

RNA interference of HIV replication.

Martínez MA, Clotet B, Esté JA. Martínez MA, et al. Among authors: clotet b. Trends Immunol. 2002 Dec;23(12):559-61. doi: 10.1016/s1471-4906(02)02328-1. Trends Immunol. 2002. PMID: 12464559

6

Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events.

Blanco J, Barretina J, Ferri KF, Jacotot E, Gutiérrez A, Armand-Ugón M, Cabrera C, Kroemer G, Clotet B, Esté JA. Blanco J, et al. Among authors: clotet b. Virology. 2003 Jan 20;305(2):318-29. doi: 10.1006/viro.2002.1764. Virology. 2003. PMID: 12573577 Free article.

7

Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression.

Llano A, Barretina J, Gutiérrez A, Clotet B, Esté JA. Llano A, et al. Among authors: clotet b. J Virol. 2003 Apr;77(7):4389-95. doi: 10.1128/jvi.77.7.4389-4395.2003. J Virol. 2003. PMID: 12634395 Free PMC article.

8

Reduced fitness of HIV-1 resistant to CXCR4 antagonists.

Armand-Ugón M, Quiñones-Mateu ME, Gutiérez A, Barretina J, Blanco J, Schols D, De Clercq E, Clotet B, Esté JA. Armand-Ugón M, et al. Among authors: clotet b. Antivir Ther. 2003 Feb;8(1):1-8. Antivir Ther. 2003. PMID: 12713058

9

Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.

Barretina J, Blanco J, Armand-Ugón M, Gutiérrez A, Clotet B, Esté JA. Barretina J, et al. Among authors: clotet b. Antivir Ther. 2003 Apr;8(2):155-61. Antivir Ther. 2003. PMID: 12741628

10

HIV-1 resistance to the gp41-dependent fusion inhibitor C-34.

Armand-Ugón M, Gutiérrez A, Clotet B, Esté JA. Armand-Ugón M, et al. Among authors: clotet b. Antiviral Res. 2003 Jul;59(2):137-42. doi: 10.1016/s0166-3542(03)00071-8. Antiviral Res. 2003. PMID: 12895697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,144 results

Search Page